BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. G-protein-coupled receptor binding, Pseudomonas infection, Neuron, Nosology, CXCL2)
Bookmark Forward

QuickView for anti infective agents (compound)


Genetic Markers

Most Correlated Genes

  1. ATF3
  2. CXCL10
  3. IFIT1
  4. RSAD2
  5. EGR1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. heterocyclic compound binding
  2. organic cyclic compound binding
  3. PILON_KLF1_TARGETS_DN
  4. organic cyclic compound metabolic process
  5. regulation of nitrogen compound metabolic process
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Bronchial epithelial cells in air-liquid interface (ALI) treated with IL-17 and IL-22
  2. Pulmonary artery smooth muscle gene expression before or after exposure to S-nitrosoglutathione
  3. Scott syndrome B-lymphoblast ionophore treatment
  4. Rhabdomyosarcoma A673 cell treatments: Cytarabine, Doxorubicin and Puromycin
  5. Glucocorticoid resistance in acute lymphoblastic leukemia and rapamycin in resistance reversal
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.
  2. Trends in anti-infective drugs use in pregnancy.
  3. Bacteriophages as anti-infective agents: recent developments and regulatory challenges.
  4. Susceptibility test of the Mycobacterium avium complex to sixteen anti-infective agents].
  5. Making space for anti-infective drug discovery.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Impact of Therapeutic Drug Monitoring on Anti-Infective Agents Amongst Severely Burned Patients Requ…
  2. Oral Anti-Infective Agent for Esophageal Anastomotic Leakage
  3. Anti Infective Agents Impact in COVID-19 Pneumonia
  4. To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-…
  5. To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.